ArticleACS applied materials & interfaces2026
Manufacturing Silk Fibroin Hollow Nanoyarns as Fundamental Units for Advanced Medical Textiles.
Article in ACS applied materials & interfaces, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nature-inspired designs aim to replicate the hierarchical structure observed in native tissues. Fibers serve as fundamental modular units, enabling the fabrication of complex architectures for the engineering of medical textiles and tissue equivalents. However, synthetic yarns lack inherent biological cues to support tissue integration, leading to a growing interest in yarns derived from natural materials. Here, we describe for the first time the fabrication of hollow nanoyarns from pure silk fibroin (SF) using an advanced funnel electrospinning process. This yielded long SF nanoyarns, spanning several meters, with adequate tensile strength (1.47 MPa) and stretching performance (166.4%). Moreover, the yarns were compatible with autoclaving, permitting effective sterilization and long-term storage, making them suitable for biomedical applications. Indirect cytocompatibility assessment of the scaffolds in accordance with ISO 10993-5 guidelines revealed high metabolic activity for human umbilical vein endothelial cells and human smooth muscle cells, confirming that the scaffolds were nontoxic. Analysis of TNF-α secretion by macrophages showed that the SF scaffolds exhibited low immunogenicity. Furthermore, the structural resilience and flexibility of the yarns supported bottom-up assembly into textile constructs by weaving. This study not only shows for the first time the feasibility of producing SF nanoyarns but also highlights their compelling potential in the field of sustainable and medical textiles.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.